Echo Therapeutics, Inc. (Echo Therapeutics) is a medical device and a speciality pharmaceutical company, which holds expertise in developing advanced skin permeation technologies. The company focuses on the development of technologies for skin permeation and continuous glucose monitoring. Its product portfolio includes Symphony CGM System, a continuous glucose monitoring system for identifying patients with diabetesand Prelude SkinPrep system, a needle free skin preparation component of Symphony that finds application in analyte extraction and needle-free drug delivery. Echo Therapeutics by utilizing its proprietary AzoneTS transdermal drug reformulation technology also develops Durhalieve, for treatment of corticosteroid-responsive dermatoses. The company works in partnerships with companies such as Ferndale Pharma Group, Inc., Medical Technologies Innovation Asia, Ltd. and Handok Pharmaceuticals to develop, market and sell its products. Echo Therapeutics is headquartered in Iselin, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Echo Therapeutics, Inc.
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio